She is the principal investigator for the New York Coordinating Center of CONCOR-1, one of the largest Covid-19 convalescent plasma randomized clinical trials in the world. Normally, such questions would be resolved by randomized clinical trials, but completing such trials may now be difficult or even impossible. All the more reason, then, to understand the strengths and weaknesses of CCP therapy. The scientific basis of CCP therapy is giving an outside boost to a patient battling the virus. Join us on Twitter and FacebookBut to use CCP therapy effectively, only the most antibody-rich plasma should be used.

Source: CNN August 29, 2020 00:22 UTC